What is Ahn-Gook Pharmaceutical Co., Ltd.'s (001540.KQ) StockRank?

MoatMap's StockRank for Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) is 100/100, with a Strong Buy signal. This is a composite score combining Quality (71), Value (89), and Momentum (73) factor ranks across MoatMap's 20,000+ stock universe.

Does Ahn-Gook Pharmaceutical Co., Ltd. have an economic moat?

Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Ahn-Gook Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) is Strong Buy, based on a StockRank of 100/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Ahn-Gook Pharmaceutical Co., Ltd. in?

Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

001540.KQ

Strong BuyFull HouseREMOVE

Ahn-Gook Pharmaceutical Co., Ltd. · Healthcare · South Korea · $91M · Avg Vol: $719K/d

100

StockRank

Get insider-trade alerts

P/E (TTM)

16.2x

ROE

12.6%

D/E

0.4x

Dividend %

6.0%

AI CONVICTION THESIS

Despite analyst sentiment, the company lacks a clearly articulated asymmetric catalyst related to the current macro themes; generic pharmaceutical exposure is not a high-conviction play.

COMPANY DESCRIPTION

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

FINANCIAL SUMMARY (KRW)

Year	2022	2023	2024	2025	CAGR	TTM
Revenue	205.4B	233.7B	271.1B	306.9B	14.3%	342.9B
EPS (KRW)	604.00	114.00	1,482	658.00	2.9%	653.80
Shares	11.4M	11.4M	11.4M	11.4M	0.0%	11.4M
Debt	20.0B	17.7B	77.7B	73.1B	54.0%	77.6B
Equity	154.8B	152.1B	165.7B	165.4B	2.2%	—
Op CF	1.8B	-1.3B	4.9B	45.7B	194.5%	39.1B
Inv CF	6.4B	17.2B	-75.4B	-12.4B	—	—
Fin CF	-3.7B	-5.1B	57.2B	-10.2B	—	—

Loading 1Y...

PRICE (1Y)-8.9%

SMA 50SMA 200

$7.59

RSI (14)

36.5

52W High

$10.17

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

4.6%58.1

ROE

12.6%79.2

GP/Assets

83.3%96.3

Op. Margin

9.4%63.8

FCF/Assets

14.0%92.8

Piotroski

784.3

Int. Cover

3.8x50.5

D/E Ratio

0.43x32.7

Current Ratio

1.69x31.3

Value

P/E (TTM)

16.2x67.2

EV/EBITDA

4.0x94.4

P/FCF

3.2x96.4

P/B

0.7x92.0

P/S

0.3x95.3

Div Yield

6.0%95.6

Momentum

52W High %

75%59.7

RS 6M

5%69.4

SMA 50/200

1.19x88.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

173%90.7

FUNDAMENTALS

Market Cap

$91M

P/E (Forward)

—

Gross Margin

66.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 001540.KQ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
001540.KQ	Ahn-Gook Pharmaceutical Co., Ltd.(you)	$91M	100	Strong Buy
234080.KS	JW Lifescience Corporation	$128M	93	Strong Buy
016580.KS	Whan In Pharm Co.,Ltd.	$137M	94	Strong Buy
023910.KQ	Daihan Pharmaceutical Co.,Ltd.	$116M	90	Strong Buy
096760.KS	JW Holdings Corporation	$209M	100	Strong Buy
005500.KS	Samjin Pharmaceuticals Co., Ltd.	$170M	93	Strong Buy
106190.KQ	High Tech Pharm Co., Ltd.	$86M	81	Strong Buy
001630.KS	Chong Kun Dang Holdings Corp.	$136M	86	Strong Buy
072020.KQ	Choong Ang Vaccine Laboratory Co., Ltd.	$63M	81	Strong Buy
033270.KS	Korea United Pharm Inc.	$188M	88	Strong Buy

Peer medians: ROE -0.3% · P/E 16.1x · Gross margin 43.0%

Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ): Stock Score Summary

Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) has a MoatMap StockRank of 100/100 based on Quality (71/100), Value (89/100), and Momentum (73/100) factor scores. The current signal is STRONG BUY. Despite analyst sentiment, the company lacks a clearly articulated asymmetric catalyst related to the current macro themes; generic pharmaceutical exposure is not a high-conviction play.

Key Financial Metrics

Price	$7.59
Market Cap	$91M
P/E (TTM)	16.20
Price/Book	0.73
Return on Equity	12.6%
Return on Invested Capital	4.6%
Debt/Equity	0.43x
Gross Margin	66.7%
Operating Margin	9.4%
Revenue Growth	19.6%
Dividend Yield	6.0%
Free Cash Flow	$29M

Ahn-Gook Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Ahn-Gook Pharmaceutical Co., Ltd.’s (001540.KQ) StockRank?: MoatMap’s StockRank for Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) is 100/100, with a Strong Buy signal. It is a composite of Quality (71), Value (89), and Momentum (73) factor ranks across MoatMap’s 20,000+ stock universe.
Does Ahn-Gook Pharmaceutical Co., Ltd. have an economic moat?: Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ahn-Gook Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) is Strong Buy, based on a StockRank of 100/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Ahn-Gook Pharmaceutical Co., Ltd. in?: Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).